INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

18,921 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
CP
Carey Stephen P.SVP & CFO
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$240K
2,850 sh
Jun 29, 2026Jun 30, 2026
Page 190 of 474
← PrevNext →
traded Jun 29, 2026
+1d
SEC Form 4

Evidence

8
TA
Talasaz AmirAliDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$6,120
40 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

6
EA
Eltoukhy AdamSEE REMARKS
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$65K
2,039 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

6
KJ
Knopp Kevin J.Director, President and CEO
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$25K
2,798 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

6
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Open-market sale · 10b5-1 plan
SELL$2,900
100 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

5
MF
Mehmel Robert FPresident and COO
GFFGRIFFON CORP
Open-market sale · 10b5-1 plan
SELL$390
4 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

5
MF
Mehmel Robert FPresident and COO
GFFGRIFFON CORP
Open-market sale · 10b5-1 plan
SELL$4,999
52 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

5
MF
Mehmel Robert FPresident and COO
GFFGRIFFON CORP
Open-market sale · 10b5-1 plan
SELL$22K
230 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

4
KZ
Katz ZacharyCLO and Head of Global Affairs
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$188K
12.8K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

4
HJ
Hug JoshuaDirector
RELYRemitly Global, Inc.
Open-market sale · 10b5-1 plan
SELL$379K
16.8K sh
Jun 30, 2026Jun 30, 2026
traded Jun 30, 2026
+0dSEC Form 4

Evidence

4
HJ
Hug JoshuaDirector
RELYRemitly Global, Inc.
Open-market sale · 10b5-1 plan
SELL$386K
16.8K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

1
BK
Bliss KellyPresident, U.S. Group Health
TDOCTeladoc Health, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
2,500 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

1
DJ
Daunt JohnEVP, Chief Commercial Officer
LQDTLIQUIDITY SERVICES INC
Open-market sale · 10b5-1 plan
SELL$1,528
39 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

45
LR
Leatherberry Antoinette ReneeDirector
DRCTDirect Digital Holdings, Inc.
Open-market sale
SELL$198
67 sh
Jun 9, 2026Jun 29, 2026
traded Jun 9, 2026
+20dSEC Form 4

Evidence

41
LM
Locke MistelleDirector
DRCTDirect Digital Holdings, Inc.
Open-market sale
SELL$72.75
25 sh
Jun 12, 2026Jun 29, 2026
traded Jun 12, 2026
+17dSEC Form 4

Evidence

41
LM
Locke MistelleDirector
DRCTDirect Digital Holdings, Inc.
Open-market sale
SELL$225
76 sh
Jun 9, 2026Jun 29, 2026
traded Jun 9, 2026
+20dSEC Form 4

Evidence

40
LM
Locke MistelleDirector
DRCTDirect Digital Holdings, Inc.
Open-market sale
SELL$202
31 sh
Jan 16, 2026Jun 29, 2026
traded Jan 16, 2026
+164dSEC Form 4

Evidence

37
LR
Leatherberry Antoinette ReneeDirector
DRCTDirect Digital Holdings, Inc.
Open-market sale
SELL$66.93
23 sh
Jun 12, 2026Jun 29, 2026
traded Jun 12, 2026
+17dSEC Form 4

Evidence

37
BD
Brazeal Mark DavidChief Legal & Corp Affairs Ofc
AVGOBroadcom Inc.
Open-market sale
SELL$9.68M
25.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

37
KJ
Kuang JinCFO
VPLMVoip-pal.com Inc
Open-market sale
SELL$2,575
250.0K sh
Jun 22, 2026Jun 29, 2026
traded Jun 22, 2026
+7dSEC Form 4

Evidence

37
KJ
Kuang JinCFO
VPLMVoip-pal.com Inc
Open-market sale
SELL$2,525
250.0K sh
Jun 24, 2026Jun 29, 2026
traded Jun 24, 2026
+5dSEC Form 4

Evidence

34
WB
Williams Kevin BryanDirector
VPLMVoip-pal.com Inc
Open-market sale
SELL$2,500
250.0K sh
Jun 24, 2026Jun 29, 2026
traded Jun 24, 2026
+5dSEC Form 4

Evidence

33
BB
Baggio BarbaraWIFE OF CEO
VPLMVoip-pal.com Inc
Open-market sale
SELL$150
15.0K sh
Jun 22, 2026Jun 29, 2026
traded Jun 22, 2026
+7dSEC Form 4

Evidence

33
WB
Williams Kevin BryanDirector
VPLMVoip-pal.com Inc
Open-market sale
SELL$2,550
250.0K sh
Jun 23, 2026Jun 29, 2026
traded Jun 23, 2026
+6dSEC Form 4

Evidence

33
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$794K
40.6K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

33
WD
Walker Mark DDirector, Chairman and CEO
DRCTDirect Digital Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$3,816
1,363 sh
Jun 12, 2026Jun 29, 2026
traded Jun 12, 2026
+17dSEC Form 4

Evidence

33
WB
Williams Kevin BryanDirector
VPLMVoip-pal.com Inc
Open-market sale
SELL$2,400
240.0K sh
Jun 22, 2026Jun 29, 2026
traded Jun 22, 2026
+7dSEC Form 4

Evidence

33
WB
Williams Kevin BryanDirector
VPLMVoip-pal.com Inc
Open-market sale
SELL$100
10.0K sh
Jun 22, 2026Jun 29, 2026
traded Jun 22, 2026
+7dSEC Form 4

Evidence

33
Robinhood Markets, Inc.10% Owner
RVIRobinhood Ventures Fund I
Open-market sale
SELL$21.64M
700.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

33
BB
Baggio BarbaraWIFE OF CEO
VPLMVoip-pal.com Inc
Open-market sale
SELL$2,468
235.0K sh
Jun 22, 2026Jun 29, 2026
traded Jun 22, 2026
+7dSEC Form 4

Evidence

33
BB
Baggio BarbaraWIFE OF CEO
VPLMVoip-pal.com Inc
Open-market sale
SELL$2,525
250.0K sh
Jun 24, 2026Jun 29, 2026
traded Jun 24, 2026
+5dSEC Form 4

Evidence

29
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$298K
14.4K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

25
HY
Huang YingDirector, Chief Executive Officer
LEGNLegend Biotech Corp
Open-market sale
SELL$82K
5,566 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

24
GE
Giles Bryan ECHIEF FINANCIAL OFFICER
AVOMission Produce, Inc.
Open-market sale
SELL$61K
5,000 sh
Jun 29, 2026Jun 29, 2026
traded Jun 29, 2026
+0dSEC Form 4

Evidence

23
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$387K
7,878 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

20
LJ
Lieffrig JohnVP and Division Manager
MGRCMCGRATH RENTCORP
Open-market sale · 10b5-1 plan
SELL$250K
2,000 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

18
BS
Bobulsky SusanChief Commercial Officer, MRD
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$103K
5,000 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

18
DA
D'Amico AndrewDirector
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$67K
200 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

18
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$70K
211 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

18
DA
D'Amico AndrewDirector
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$106K
331 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence